Title : Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma.

Pub. Date : 2006 Mar

PMID : 16303861






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Leucovorin epidermal growth factor receptor Homo sapiens